These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 20103644)
1. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644 [TBL] [Abstract][Full Text] [Related]
2. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance. Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510 [TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. Grum-Schwensen B; Klingelhofer J; Berg CH; El-Naaman C; Grigorian M; Lukanidin E; Ambartsumian N Cancer Res; 2005 May; 65(9):3772-80. PubMed ID: 15867373 [TBL] [Abstract][Full Text] [Related]
4. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508 [TBL] [Abstract][Full Text] [Related]
7. Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice. Lanza DG; Ma J; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S Tumour Biol; 2012 Dec; 33(6):1997-2005. PubMed ID: 22836804 [TBL] [Abstract][Full Text] [Related]
8. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice. Decock J; Hendrickx W; Thirkettle S; Gutiérrez-Fernández A; Robinson SD; Edwards DR Breast Cancer Res; 2015 Mar; 17(1):38. PubMed ID: 25848906 [TBL] [Abstract][Full Text] [Related]
9. Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer. Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; Sibson DR; Davies MP Int J Exp Pathol; 2003 Aug; 84(4):173-84. PubMed ID: 14632631 [TBL] [Abstract][Full Text] [Related]
10. Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion. Klingelhöfer J; Grum-Schwensen B; Beck MK; Knudsen RS; Grigorian M; Lukanidin E; Ambartsumian N Neoplasia; 2012 Dec; 14(12):1260-8. PubMed ID: 23308057 [TBL] [Abstract][Full Text] [Related]
11. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. O'Connell JT; Sugimoto H; Cooke VG; MacDonald BA; Mehta AI; LeBleu VS; Dewar R; Rocha RM; Brentani RR; Resnick MB; Neilson EG; Zeisberg M; Kalluri R Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16002-7. PubMed ID: 21911392 [TBL] [Abstract][Full Text] [Related]
12. Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice. Forst B; Hansen MT; Klingelhöfer J; Møller HD; Nielsen GH; Grum-Schwensen B; Ambartsumian N; Lukanidin E; Grigorian M PLoS One; 2010 Apr; 5(4):e10374. PubMed ID: 20442771 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein. Klingelhöfer J; Møller HD; Sumer EU; Berg CH; Poulsen M; Kiryushko D; Soroka V; Ambartsumian N; Grigorian M; Lukanidin EM FEBS J; 2009 Oct; 276(20):5936-48. PubMed ID: 19740107 [TBL] [Abstract][Full Text] [Related]
14. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis. Ricciardelli C; Frewin KM; Tan Ide A; Williams ED; Opeskin K; Pritchard MA; Ingman WV; Russell DL Am J Pathol; 2011 Dec; 179(6):3075-85. PubMed ID: 22001177 [TBL] [Abstract][Full Text] [Related]
15. Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model. Ma J; Lanza DG; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S Tumour Biol; 2012 Dec; 33(6):1983-96. PubMed ID: 22878936 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model. Franci C; Zhou J; Jiang Z; Modrusan Z; Good Z; Jackson E; Kouros-Mehr H PLoS One; 2013; 8(3):e58183. PubMed ID: 23520493 [TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971 [TBL] [Abstract][Full Text] [Related]
18. The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Hollern DP; Honeysett J; Cardiff RD; Andrechek ER Mol Cell Biol; 2014 Sep; 34(17):3229-43. PubMed ID: 24934442 [TBL] [Abstract][Full Text] [Related]
19. Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model. Almholt K; Juncker-Jensen A; Laerum OD; Danø K; Johnsen M; Lund LR; Rømer J Mol Cancer Ther; 2008 Sep; 7(9):2758-67. PubMed ID: 18790756 [TBL] [Abstract][Full Text] [Related]
20. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages. Haase-Kohn C; Wolf S; Herwig N; Mosch B; Pietzsch J Biochem Biophys Res Commun; 2014 Mar; 446(1):143-8. PubMed ID: 24613382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]